The Immunomodulatory Properties of Mesenchymal Stem Cells Play a Critical Role in Inducing Immune Tolerance after Liver Transplantation
Open Access
- 4 September 2021
- journal article
- review article
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-14
Abstract
Although liver transplantation is considered to be the best choice for patients with end-stage liver diseases, postoperative immune rejection still cannot be overlooked. Patients with liver transplantation have to take immunosuppressive drugs for a long time or even their entire lives, in which heavy economic burden and side effects caused by the drugs have become the major impediment for liver transplantation. There is a growing body of evidences indicating that mesenchymal stem cell (MSC) transplantation, a promising tool in regenerative medicine, can be used as an effective way to induce immune tolerance after liver transplantation based on their huge expansion potential and unique immunomodulatory properties. MSCs have been reported to inhibit innate immunity and adaptive immunity to induce a tolerogenic microenvironment. In in vitro studies, transplanted MSCs show plasticity in immune regulation by altering their viability, migration, differentiation, and secretion in the interactions with the surrounding host microenvironment. In this review, we aim to provide an overview of the current understanding of immunomodulatory properties of MSCs in liver transplantation, to elucidate the potential mechanisms behind MSCs regulating immune response, especially in vivo and the influence of the microenvironment, and ultimately to discuss the feasible strategies to improve the clinical prognosis of liver transplantation. Only after exhaustive understanding of potential mechanisms of the MSC immunomodulation can we improve the safety and effectiveness of MSC treatment and achieve better therapeutic effects.Keywords
Funding Information
- Key Technology Research and Development Program of Zhejiang Province (2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Open Project Program of Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province (2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Major Research Program of Taizhou EnzeMedical Center Grant (2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Program of Taizhou Science and Technology Grant (2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Medical Science and Technology Project of Zhejiang Province (2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
This publication has 121 references indexed in Scilit:
- The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic miceBiomaterials, 2012
- Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-à-go-go 1 (hEAG1) potassium channelAmerican Journal of Physiology-Cell Physiology, 2012
- Antigen-presenting cell function in the tolerogenic liver environmentNature Reviews Immunology, 2010
- Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejectionEuropean Journal of Immunology, 2010
- Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3− regulatory T cells suppressing autoimmune hepatitis†Hepatology, 2009
- Mouse Mesenchymal Stem Cells Suppress Antigen-Specific TH Cell Immunity Independent of Indoleamine 2,3-Dioxygenase 1 (IDO1)Stem Cells and Development, 2009
- Immunosuppressive Function of Bone Marrow Mesenchymal Stem Cells on Acute Rejection of Liver Allografts in RatsTransplantation Proceedings, 2009
- The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosisStem Cell Research, 2009
- Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCsStem Cells, 2006
- Inducing hepatic differentiation of human mesenchymal stem cells in pellet cultureBiomaterials, 2006